Working in partnership with NHS Supply Chain
£35.00
E7 Oncoprotein Test Kit – Detection of Cervical Cancer – Speculum Included – Small
The E7 rapid detection kit is suitable for women aged 18-70 as a technical product for the prevention and detection of cervical precancerous lesions.
The purpose of frequent E7 protein testing is not only to monitor the presence of precancerous lesions or cancers, but also as a screening tool to prevent the development of cervical cancer.
The E7 protein test kit detects E7 protein, expressions of E7 Protein in Cervical epithelial cells and cervical cancer lesions. E7 protein reflects patient lesions and is one of the main indicators for cervical cancer risk assessment. The E7 test has high accuracy as it uses colloidal gold screening methods and is easy to operate and provides fast accurate results.
EXCLUSIONS: 3 days before the test, the patient should abstain from sexual intercourse and limit care treatments in the genital area (depilation). 3 Days before the sample is taken, the patient must not use any intravaginal medications or external ointments. The test is not performed in patients during menstruation or pregnancy. A swab should not be taken 3 days before and 3 days after menstruation. If there is abnormal or heavy vaginal bleeding or excessive and thick discharge, the sample collection should be postponed. A break of 1 day should be observed after the gynaecological examination or ultrasound.